-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on IDEAYA Biosciences, Raises Price Target to $60

Benzinga·01/06/2026 15:13:37
Listen to the news
Truist Securities analyst Gregory Renza maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and raises the price target from $59 to $60.